Boston Scientific Corporation (NYSE:BSX) Signs Agreement To Sell Its BTG Specialty Pharmaceutical Business
Boston Scientific Corporation (NYSE:BSX) has announced the signing of a definitive agreement with European specialty pharmaceutical group, SERB’s affiliates SERB
Read more